Effect of apolipoprotein E allele ε4 on the initial phase of amyloid β-protein accumulation in the human brain

被引:99
|
作者
Morishima-Kawashima, M
Oshima, N
Ogata, H
Yamaguchi, H
Yoshimura, M
Sugihara, S
Ihara, Y
机构
[1] Univ Tokyo, Fac Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Japan Sci & Technol Corp, Kawaguchi, Japan
[3] Natl Inst Publ Hlth, Tokyo, Japan
[4] Gunma Univ, Sch Hlth Sci, Maebashi, Gumma 371, Japan
[5] Kyoto Prefectural Univ Med, Kyoto, Japan
[6] Gunma Canc Ctr, Ohta, Japan
来源
AMERICAN JOURNAL OF PATHOLOGY | 2000年 / 157卷 / 06期
关键词
D O I
10.1016/S0002-9440(10)64847-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Deposition of amyloid. beta -protein (A beta), a hallmark of Alzheimer's disease, occurs to some extent in the brains of most elderly individuals. We sought to learn when A beta deposition begins and how deposition is affected by apolipoprotein E allele epsilon4, a strong risk factor for late-onset Alzheimer's disease. Using an improved extraction protocol and specific enzyme-linked immunosorbent assay, we quantified the levels of A beta 40 and A beta 42 in the insoluble fractions of brains from 105 autopsy cases, aged 22 to 81 years at death, who showed no signs of dementia. A beta 40 and A beta 42 were detected in the insoluble fractions from all of the brains examined; low levels were even found in the brains of patients as young as 20 to 30 years of age. The incidence of significant A beta accumulation increased age-dependently, with A beta 42 levels beginning to rise steeply in some patients in their late 40's, accompanied by much smaller increases in A beta 40 levels. The presence of the apolipoprotein E epsilon4 allele was found to significantly enhance the accumulation of A beta 42 and, to a lesser extent, that of A beta 40. These findings strongly suggest that the presence of epsilon4 allele results in an earlier onset of A beta 42 accumulation in the brain.
引用
收藏
页码:2093 / 2099
页数:7
相关论文
共 50 条
  • [21] Cerebral amyloid angiopathy and apolipoprotein E: Bad news for the good allele?
    Greenberg, SM
    Hyman, BT
    ANNALS OF NEUROLOGY, 1997, 41 (06) : 701 - 702
  • [22] A high incidence of apolipoprotein E ε4 allele in middle-aged non-demented subjects with cerebral amyloid β protein deposits
    Arai, T
    Ikeda, K
    Akiyama, H
    Haga, C
    Usami, M
    Sahara, N
    Iritani, S
    Mori, H
    ACTA NEUROPATHOLOGICA, 1999, 97 (01) : 82 - 84
  • [23] APOLIPOPROTEIN-E EPSILON-4 ALLELE IS ASSOCIATED WITH DEPOSITION OF AMYLOID BETA-PROTEIN FOLLOWING HEAD-INJURY
    NICOLL, JAR
    ROBERTS, GW
    GRAHAM, DI
    NATURE MEDICINE, 1995, 1 (02) : 135 - 137
  • [24] A high incidence of apolipoprotein E ε4 allele in middle-aged non-demented subjects with cerebral amyloid β protein deposits
    T. Arai
    Kenji Ikeda
    Haruhiko Akiyama
    Chie Haga
    Mihoko Usami
    Naruhiko Sahara
    Shuji Iritani
    Hiroshi Mori
    Acta Neuropathologica, 1999, 97 : 82 - 84
  • [25] Association between Amylin and Amyloid-β Peptides in Plasma in the Context of Apolipoprotein E4 Allele
    Qiu, Wei Qiao
    Wallack, Max
    Dean, Michael
    Liebson, Elizabeth
    Mwamburi, Mkaya
    Zhu, Haihao
    PLOS ONE, 2014, 9 (02):
  • [26] Age and apolipoprotein E*4 allele effects on cerebrospinal fluid β-amyloid 42 in adults with normal cognition
    Peskind, Elaine R.
    Li, Ge
    Shofer, Jane
    Quinn, Joseph F.
    Kaye, Jeffrey A.
    Clark, Chris M.
    Farlow, Martin R.
    DeCarli, Charles
    Raskind, Murray A.
    Schellenberg, Gerard D.
    Lee, Virginia M. -Y.
    Galasko, Douglas R.
    ARCHIVES OF NEUROLOGY, 2006, 63 (07) : 936 - 939
  • [27] The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks
    Frank, Conner
    Albertazzi, Abigail
    Murphy, Claire
    BRAIN AND BEHAVIOR, 2024, 14 (05):
  • [28] Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
    Mattsson, Niklas
    Groot, Colin
    Jansen, Willemijn J.
    Landau, Susan M.
    Villemagne, Victor L.
    Engelborghs, Sebastiaan
    Mintun, Mark M.
    Lleo, Alberto
    Molinuevo, Jose Luis
    Jagust, William J.
    Frisoni, Giovanni B.
    Ivanoiu, Adrian
    Chetelat, Gael
    de Oliveira, Catarina Resende
    Rodrigue, Karen M.
    Kornhuber, Johannes
    Wallin, Anders
    Klimkowicz-Mrowiec, Aleksandra
    Kandimalla, Ramesh
    Popp, Julius
    Aalten, Pauline P.
    Aarsland, Dag
    Alcolea, Daniel
    Almdahl, Ina S.
    Baldeiras, Ines
    van Buchem, Mark A.
    Cavedo, Enrica
    Chen, Kewei
    Cohen, Ann D.
    Foerster, Stefan
    Fortea, Juan
    Frederiksen, Kristian S.
    Freund-Levi, Yvonne
    Gill, Kiran Dip
    Gkatzima, Olymbia
    Grimmer, Timo
    Hampel, Harald
    Herukka, Sanna-Kaisa
    Johannsen, Peter
    van Laere, Koen
    de Leon, Mony J.
    Maier, Wolfgang
    Marcusson, Jan
    Meulenbroek, Olga
    Mollergard, Hanne M.
    Morris, John C.
    Mroczko, Barbara
    Nordlund, Arto
    Prabhakar, Sudesh
    Peters, Oliver
    ALZHEIMERS & DEMENTIA, 2018, 14 (07) : 913 - 924
  • [29] Alterations in cerebrospinal fluid apolipoprotein E and amyloid β-protein after traumatic brain injury
    Kay, AD
    Petzold, A
    Kerr, M
    Keir, G
    Thompson, E
    Nicoll, JAR
    JOURNAL OF NEUROTRAUMA, 2003, 20 (10) : 943 - 952
  • [30] Influence of idebenone on amyloid precursor protein and apolipoprotein E expression in ischemic rat brain
    Pluta, R
    Barcikowska, M
    Debicki, G
    Ryba, M
    Januszewski, S
    BRAIN PATHOLOGY, 1997, 7 (04) : 1211 - 1211